{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:28:28Z","timestamp":1791404908982,"version":"4.3.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T00:00:00Z","timestamp":1474934400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T00:00:00Z","timestamp":1474934400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P50AR060752, P50AR063043, R01 AR043052, R01 AR061366"],"award-info":[{"award-number":["P50AR060752, P50AR063043, R01 AR043052, R01 AR061366"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007557","name":"California Institute of Regenerative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007557","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00223-016-0195-6","type":"journal-article","created":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T15:29:12Z","timestamp":1474990152000},"page":"67-79","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A Novel Hybrid Compound LLP2A-Ale Both Prevented and Rescued the Osteoporotic Phenotype in a Mouse Model of Glucocorticoid-Induced Osteoporosis"],"prefix":"10.1007","volume":"100","author":[{"given":"Geetha","family":"Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan Yu-An","family":"Lay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Berka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Ringwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,27]]},"reference":[{"key":"195_CR1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ecl.2012.04.004","volume":"41","author":"RS Weinstein","year":"2012","unstructured":"Weinstein RS (2012) Glucocorticoid-induced osteoporosis and osteonecrosis. Endocrinol Metab Clin North Am 41:595\u2013611","journal-title":"Endocrinol Metab Clin North Am"},{"key":"195_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0169-6009(91)90139-Q","volume":"8","author":"V LoCascio","year":"1990","unstructured":"LoCascio V, Bonucci E, Imbimbo B et al (1990) Bone loss in response to long-term glucocorticoid therapy. Bone Miner 8:39\u201351","journal-title":"Bone Miner"},{"key":"195_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bone.2006.02.005","volume":"39","author":"A Angeli","year":"2006","unstructured":"Angeli A, Guglielmi G, Dovio A et al (2006) High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39:253\u2013259","journal-title":"Bone"},{"key":"195_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00198-003-1548-3","volume":"15","author":"M Steinbuch","year":"2004","unstructured":"Steinbuch M, Youket TE, Cohen S (2004) Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int: J Establ Result Coop Between Eur Found Osteoporos Nat Osteoporos Found USA 15:323\u2013328","journal-title":"Osteoporos Int: J Establ Result Coop Between Eur Found Osteoporos Nat Osteoporos Found USA"},{"key":"195_CR5","first-page":"883","volume":"85","author":"EO Abu","year":"2000","unstructured":"Abu EO, Horner A, Kusec V et al (2000) The localization of the functional glucocorticoid receptor alpha in human bone. J Clin Endocrinol Metab 85:883\u2013889","journal-title":"J Clin Endocrinol Metab"},{"key":"195_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1172\/JCI2799","volume":"102","author":"RS Weinstein","year":"1998","unstructured":"Weinstein RS, Jilka RL, Parfitt AM et al (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Investig 102:274\u2013282","journal-title":"J Clin Investig"},{"key":"195_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/03008200009005641","volume":"41","author":"Q Cui","year":"2000","unstructured":"Cui Q, Wang GJ, Balian G (2000) Pluripotential marrow cells produce adipocytes when transplanted into steroid-treated mice. Connect Tissue Res 41:45\u201356","journal-title":"Connect Tissue Res"},{"key":"195_CR8","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.bone.2009.06.030","volume":"46","author":"RS Weinstein","year":"2010","unstructured":"Weinstein RS (2010) Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularity. Bone 46:564\u2013570","journal-title":"Bone"},{"key":"195_CR9","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/ncb3067","volume":"16","author":"N Ono","year":"2014","unstructured":"Ono N, Ono W, Nagasawa T et al (2014) A subset of chondrogenic cells provides early mesenchymal progenitors in growing bones. Nat Cell Biol 16:1157\u20131167","journal-title":"Nat Cell Biol"},{"key":"195_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1242\/bio.201411031","volume":"4","author":"J Park","year":"2015","unstructured":"Park J, Gebhardt M, Golovchenko S et al (2015) Dual pathways to endochondral osteoblasts: a novel chondrocyte-derived osteoprogenitor cell identified in hypertrophic cartilage. Biol Open 4:608\u2013621","journal-title":"Biol Open"},{"key":"195_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1152\/physrev.00011.2015","volume":"96","author":"K Hartmann","year":"2016","unstructured":"Hartmann K, Koenen M, Schauer S et al (2016) Molecular actions of glucocorticoids in cartilage and bone during health, disease, and steroid therapy. Physiol Rev 96:409\u2013447","journal-title":"Physiol Rev"},{"key":"195_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ajpath.2013.03.004","volume":"183","author":"LJ Janke","year":"2013","unstructured":"Janke LJ, Liu C, Vogel P et al (2013) Primary epiphyseal arteriopathy in a mouse model of steroid-induced osteonecrosis. Am J Pathol 183:19\u201325","journal-title":"Am J Pathol"},{"key":"195_CR13","first-page":"2155","volume":"87","author":"KA Lai","year":"2005","unstructured":"Lai KA, Shen WJ, Yang CY et al (2005) The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am 87:2155\u20132159","journal-title":"J Bone Joint Surg Am"},{"key":"195_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.rdc.2015.08.005","volume":"42","author":"X Whittier","year":"2016","unstructured":"Whittier X, Saag KG (2016) Glucocorticoid-induced osteoporosis. Rheum Dis Clin North Am 42:177\u2013189","journal-title":"Rheum Dis Clin North Am"},{"key":"195_CR15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMra067395","volume":"357","author":"E Canalis","year":"2007","unstructured":"Canalis E, Giustina A, Bilezikian JP (2007) Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 357:905\u2013916","journal-title":"N Engl J Med"},{"key":"195_CR16","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1002\/art.24879","volume":"60","author":"KG Saag","year":"2009","unstructured":"Saag KG, Zanchetta JR, Devogelaer JP et al (2009) Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial. Arthritis Rheum 60:3346\u20133355","journal-title":"Arthritis Rheum"},{"key":"195_CR17","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1210\/en.2009-1488","volume":"151","author":"RS Weinstein","year":"2010","unstructured":"Weinstein RS, Jilka RL, Almeida M et al (2010) Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice. Endocrinology 151:2641\u20132649","journal-title":"Endocrinology"},{"key":"195_CR18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.beem.2014.09.002","volume":"28","author":"JM Kaufman","year":"2014","unstructured":"Kaufman JM, Lapauw B, Goemaere S (2014) Current and future treatments of osteoporosis in men. Best Pract Res Clin Endocrinol Metab 28:871\u2013884","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"195_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/jcph.239","volume":"54","author":"D Padhi","year":"2014","unstructured":"Padhi D, Allison M, Kivitz AJ et al (2014) Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: a randomized, double-blind, placebo-controlled study. J Clin Pharmacol 54:168\u2013178","journal-title":"J Clin Pharmacol"},{"key":"195_CR20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1056\/NEJMoa1305224","volume":"370","author":"MR McClung","year":"2014","unstructured":"McClung MR, Grauer A, Boonen S et al (2014) Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med 370:412\u2013420","journal-title":"N Engl J Med"},{"key":"195_CR21","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.bone.2015.09.010","volume":"81","author":"Z Achiou","year":"2015","unstructured":"Achiou Z, Toumi H, Touvier J et al (2015) Sclerostin antibody and interval treadmill training effects in a rodent model of glucocorticoid-induced osteopenia. Bone 81:691\u2013701","journal-title":"Bone"},{"key":"195_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00198-015-3308-6","volume":"27","author":"W Yao","year":"2016","unstructured":"Yao W, Dai W, Jiang L et al (2016) Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength. Osteoporos Int: J Establ Result Coop Between Eur Found Osteoporos Nat Osteoporos Found USA 27:283\u2013294","journal-title":"Osteoporos Int: J Establ Result Coop Between Eur Found Osteoporos Nat Osteoporos Found USA"},{"key":"195_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nchembio798","volume":"2","author":"L Peng","year":"2006","unstructured":"Peng L, Liu R, Marik J et al (2006) Combinatorial chemistry identifies high-affinity peptidomimetics against \u03b14\u03b21 integrin for in vivo tumor imaging. Nat Chem Biol 2:381\u2013389","journal-title":"Nat Chem Biol"},{"key":"195_CR24","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/nm.2665","volume":"18","author":"M Guan","year":"2012","unstructured":"Guan M, Yao W, Liu R et al (2012) Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med 18:456\u2013462","journal-title":"Nat Med"},{"key":"195_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/bonekey.2012.115","volume":"9","author":"S Herberg","year":"2012","unstructured":"Herberg S, Hill WD (2012) Two birds with one bone? IBMS BoneKEy. 9:115. doi:\n                    10.1038\/bonekey.2012.115","journal-title":"IBMS BoneKEy"},{"key":"195_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bone.2014.07.026","volume":"70","author":"W Yao","year":"2015","unstructured":"Yao W, Lane NE (2015) Targeted delivery of mesenchymal stem cells to the bone. Bone 70:62\u201365","journal-title":"Bone"},{"key":"195_CR27","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/stem.1461","volume":"31","author":"W Yao","year":"2013","unstructured":"Yao W, Guan M, Jia J et al (2013) Reversing bone loss by directing mesenchymal stem cells to bone. Stem Cells 31:2003\u20132014","journal-title":"Stem Cells"},{"key":"195_CR28","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1002\/art.23454","volume":"58","author":"W Yao","year":"2008","unstructured":"Yao W, Cheng Z, Busse C et al (2008) Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis Rheum 58:1674\u20131686","journal-title":"Arthritis Rheum"},{"key":"195_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bone.2015.01.001","volume":"74","author":"W Dai","year":"2015","unstructured":"Dai W, Jiang L, Lay YA et al (2015) Prevention of glucocorticoid induced bone changes with beta-ecdysone. Bone 74:48\u201357","journal-title":"Bone"},{"key":"195_CR30","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1002\/art.23954","volume":"58","author":"W Yao","year":"2008","unstructured":"Yao W, Cheng Z, Pham A et al (2008) Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization. Arthritis Rheum 58:3485\u20133497","journal-title":"Arthritis Rheum"},{"key":"195_CR31","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1359\/JBMR.051103","volume":"21","author":"NE Lane","year":"2006","unstructured":"Lane NE, Yao W, Balooch M et al (2006) Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res: Off J Am Soc Bone Miner Res 21:466\u2013476","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"195_CR32","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH et al (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res: Off J Am Soc Bone Miner Res 2:595\u2013610","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"195_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster DW, Compston JE, Drezner MK et al (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res: Off J Am Soc Bone Miner Res 28:2\u201317","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"195_CR34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","volume":"14","author":"CH Turner","year":"1993","unstructured":"Turner CH, Burr DB (1993) Basic biomechanical measurements of bone: a tutorial. Bone 14:595\u2013608","journal-title":"Bone"},{"key":"195_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.1711700102","volume":"170","author":"B Ansari","year":"1993","unstructured":"Ansari B, Coates PJ, Greenstein BD et al (1993) In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 170:1\u20138","journal-title":"J Pathol"},{"key":"195_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jbspin.2012.01.009","volume":"80","author":"B Bouvard","year":"2013","unstructured":"Bouvard B, Gallois Y, Legrand E et al (2013) Glucocorticoids reduce alveolar and trabecular bone in mice. Joint Bone Spine: Revue Du Rhumatisme 80:77\u201381","journal-title":"Joint Bone Spine: Revue Du Rhumatisme"},{"key":"195_CR37","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bone.2012.11.038","volume":"54","author":"RL Jilka","year":"2013","unstructured":"Jilka RL, Noble B, Weinstein RS (2013) Osteocyte apoptosis. Bone 54:264\u2013271","journal-title":"Bone"},{"key":"195_CR38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1056\/NEJM199807303390502","volume":"339","author":"KG Saag","year":"1998","unstructured":"Saag KG, Emkey R, Schnitzer TJ et al (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 339:292\u2013299","journal-title":"N Engl J Med"},{"key":"195_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W","volume":"44","author":"JD Adachi","year":"2001","unstructured":"Adachi JD, Saag KG, Delmas PD et al (2001) Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum 44:202\u2013211","journal-title":"Arthritis Rheum"},{"key":"195_CR40","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1002\/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K","volume":"42","author":"S Cohen","year":"1999","unstructured":"Cohen S, Levy RM, Keller M et al (1999) Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum 42:2309\u20132318","journal-title":"Arthritis Rheum"},{"key":"195_CR41","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1359\/jbmr.2000.15.6.1006","volume":"15","author":"DM Reid","year":"2000","unstructured":"Reid DM, Hughes RA, Laan RF et al (2000) Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res: Off J Am Soc Bone Miner Res 15:1006\u20131013","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"195_CR42","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jbiomech.2005.01.012","volume":"39","author":"JS Nyman","year":"2006","unstructured":"Nyman JS, Roy A, Shen X et al (2006) The influence of water removal on the strength and toughness of cortical bone. J Biomech 39:931\u2013938","journal-title":"J Biomech"},{"key":"195_CR43","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1177\/147323001003800333","volume":"38","author":"G Wang","year":"2010","unstructured":"Wang G, Zhang CQ, Sun Y et al (2010) Changes in femoral head blood supply and vascular endothelial growth factor in rabbits with steroid-induced osteonecrosis. J Int Med Res 38:1060\u20131069","journal-title":"J Int Med Res"},{"key":"195_CR44","first-page":"315850","volume":"2015","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Liu C, Chen W et al (2015) Tetramethylpyrazine enhances vascularization and prevents osteonecrosis in steroid-treated rats. Biomed Res Int 2015:315850","journal-title":"Biomed Res Int"},{"key":"195_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/bmb\/ldt031","volume":"108","author":"SM Watt","year":"2013","unstructured":"Watt SM, Gullo F, van der Garde M et al (2013) The angiogenic properties of mesenchymal stem\/stromal cells and their therapeutic potential. Br Med Bull 108:25\u201353","journal-title":"Br Med Bull"},{"key":"195_CR46","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.4161\/cc.6.23.5095","volume":"6","author":"DG Phinney","year":"2007","unstructured":"Phinney DG (2007) Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic efficacy. Cell Cycle 6:2884\u20132889","journal-title":"Cell Cycle"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0195-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-016-0195-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0195-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T05:29:34Z","timestamp":1589693374000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-016-0195-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,27]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["195"],"URL":"https:\/\/doi.org\/10.1007\/s00223-016-0195-6","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,27]]},"assertion":[{"value":"1 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Geetha Mohan, Evan Yu-An Lay, Haley Berka, Lorna Ringwood, Alexander Kot, Haiyan Chen, Wei Yao, and Nancy E Lane declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. This study only reports data from animal experiments for which we have included the statement on animal welfare. We do not have any patient data or individual participants in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}